Evaluation of immunohistochemistry and enzyme linked immunosorbent assay for HER-2/neu expression in breast carcinoma

HER-2 is overexpressed in approximately 20–30% of invasive Breast Cancer. ECD of the HER-2 protein is frequently cleaved and released into the circulation, where it can be detected by ELISA in up to 45% of patients with metastatic breast cancer. The objective of our study was to compare the current...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: James, Rani, Thriveni, K., Ramaswamy, Girija, Krishnamoorthy, Lakshmi, Mukherjee, Geetashree, Vijayalaxmi Deshmane, P. P., Bapsy, P. P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer-Verlag 2008
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3453142/
https://ncbi.nlm.nih.gov/pubmed/23105784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12291-008-0076-5
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller